Dabigatran Effective, Safer Than Warfarin

In addition, in what Dr. Oldgren called “astonishing results,” both dabigatran dosages showed a statistically significant reduction in the rate of intracranial bleeds compared with warfarin in all three risk subgroups. The relative risk reduction ranged from 60%-70% for each of the three CHADS2 risk levels in both dabigatran dosage levels. This finding “is very important because this is the most feared complication of oral anticoagulant therapy,” Dr. Oldgren said.

Elsevier Global Medical News